Nitric Oxide Releasing Nanoparticles as a Strategy to Improve Current Onychomycosis Treatments

Caroline B. Costa-Orlandi, Breanne Mordorski, Ludmila M. Baltazar, Maria José S. Mendes-Giannini, Joel M. Friedman, Joshua D. Nosanchuk, Adam J. Friedman

Research output: Contribution to journalArticle

Abstract

Topical antimicrobials are the ideal mode of onychomycosis treatment for efficient drug delivery and avoidance of sytemic effects associated with oral medications. However, high treatment costs, tissue penetration limitations, and low cure rates have continued to pose major challenges. To capitalize on the progress made by topical efinaconazole solution, efinaconazole was combined with inexpensive, previously-characterized nitric oxide releasing nanoparticles (NO-np), which have been shown to offer sustained nitric oxide release over time and enhanced barrier penetration, while exerting broad spectrum antimicrobial and immunomodulating properties. NO-np were combined with efinaconazole in varying concentrations and applied against reference strains of Trichophyton rubrum using a checkerboard method. Results demonstrated synergism of NO-np+efinaconazole against T. rubrum, which is noteworthy given the barriers present in the topical treatment of onychomycosis, and the multiple potential benefits offered by NO-np. Overall, this study illustrates the untapped potential of nanotechnology in the treatment of disorders of the skin, hair, and nails where drug delivery remains a challenge. J Drugs Dermatol. 2018;17(7):717-720.

Original languageEnglish (US)
Pages (from-to)717-720
Number of pages4
JournalJournal of drugs in dermatology : JDD
Volume17
Issue number7
StatePublished - Jul 1 2018

Fingerprint

Onychomycosis
Nanoparticles
Nitric Oxide
Pharmaceutical Preparations
Trichophyton
Nanotechnology
Nails
Health Care Costs
Hair
Skin
efinaconazole

ASJC Scopus subject areas

  • Dermatology

Cite this

Costa-Orlandi, C. B., Mordorski, B., Baltazar, L. M., Mendes-Giannini, M. J. S., Friedman, J. M., Nosanchuk, J. D., & Friedman, A. J. (2018). Nitric Oxide Releasing Nanoparticles as a Strategy to Improve Current Onychomycosis Treatments. Journal of drugs in dermatology : JDD, 17(7), 717-720.

Nitric Oxide Releasing Nanoparticles as a Strategy to Improve Current Onychomycosis Treatments. / Costa-Orlandi, Caroline B.; Mordorski, Breanne; Baltazar, Ludmila M.; Mendes-Giannini, Maria José S.; Friedman, Joel M.; Nosanchuk, Joshua D.; Friedman, Adam J.

In: Journal of drugs in dermatology : JDD, Vol. 17, No. 7, 01.07.2018, p. 717-720.

Research output: Contribution to journalArticle

Costa-Orlandi, CB, Mordorski, B, Baltazar, LM, Mendes-Giannini, MJS, Friedman, JM, Nosanchuk, JD & Friedman, AJ 2018, 'Nitric Oxide Releasing Nanoparticles as a Strategy to Improve Current Onychomycosis Treatments', Journal of drugs in dermatology : JDD, vol. 17, no. 7, pp. 717-720.
Costa-Orlandi, Caroline B. ; Mordorski, Breanne ; Baltazar, Ludmila M. ; Mendes-Giannini, Maria José S. ; Friedman, Joel M. ; Nosanchuk, Joshua D. ; Friedman, Adam J. / Nitric Oxide Releasing Nanoparticles as a Strategy to Improve Current Onychomycosis Treatments. In: Journal of drugs in dermatology : JDD. 2018 ; Vol. 17, No. 7. pp. 717-720.
@article{1a2fe65af5eb4f429505d50ac6714898,
title = "Nitric Oxide Releasing Nanoparticles as a Strategy to Improve Current Onychomycosis Treatments",
abstract = "Topical antimicrobials are the ideal mode of onychomycosis treatment for efficient drug delivery and avoidance of sytemic effects associated with oral medications. However, high treatment costs, tissue penetration limitations, and low cure rates have continued to pose major challenges. To capitalize on the progress made by topical efinaconazole solution, efinaconazole was combined with inexpensive, previously-characterized nitric oxide releasing nanoparticles (NO-np), which have been shown to offer sustained nitric oxide release over time and enhanced barrier penetration, while exerting broad spectrum antimicrobial and immunomodulating properties. NO-np were combined with efinaconazole in varying concentrations and applied against reference strains of Trichophyton rubrum using a checkerboard method. Results demonstrated synergism of NO-np+efinaconazole against T. rubrum, which is noteworthy given the barriers present in the topical treatment of onychomycosis, and the multiple potential benefits offered by NO-np. Overall, this study illustrates the untapped potential of nanotechnology in the treatment of disorders of the skin, hair, and nails where drug delivery remains a challenge. J Drugs Dermatol. 2018;17(7):717-720.",
author = "Costa-Orlandi, {Caroline B.} and Breanne Mordorski and Baltazar, {Ludmila M.} and Mendes-Giannini, {Maria Jos{\'e} S.} and Friedman, {Joel M.} and Nosanchuk, {Joshua D.} and Friedman, {Adam J.}",
year = "2018",
month = "7",
day = "1",
language = "English (US)",
volume = "17",
pages = "717--720",
journal = "Journal of Drugs in Dermatology",
issn = "1545-9616",
publisher = "Journal of Drugs in Dermatology",
number = "7",

}

TY - JOUR

T1 - Nitric Oxide Releasing Nanoparticles as a Strategy to Improve Current Onychomycosis Treatments

AU - Costa-Orlandi, Caroline B.

AU - Mordorski, Breanne

AU - Baltazar, Ludmila M.

AU - Mendes-Giannini, Maria José S.

AU - Friedman, Joel M.

AU - Nosanchuk, Joshua D.

AU - Friedman, Adam J.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Topical antimicrobials are the ideal mode of onychomycosis treatment for efficient drug delivery and avoidance of sytemic effects associated with oral medications. However, high treatment costs, tissue penetration limitations, and low cure rates have continued to pose major challenges. To capitalize on the progress made by topical efinaconazole solution, efinaconazole was combined with inexpensive, previously-characterized nitric oxide releasing nanoparticles (NO-np), which have been shown to offer sustained nitric oxide release over time and enhanced barrier penetration, while exerting broad spectrum antimicrobial and immunomodulating properties. NO-np were combined with efinaconazole in varying concentrations and applied against reference strains of Trichophyton rubrum using a checkerboard method. Results demonstrated synergism of NO-np+efinaconazole against T. rubrum, which is noteworthy given the barriers present in the topical treatment of onychomycosis, and the multiple potential benefits offered by NO-np. Overall, this study illustrates the untapped potential of nanotechnology in the treatment of disorders of the skin, hair, and nails where drug delivery remains a challenge. J Drugs Dermatol. 2018;17(7):717-720.

AB - Topical antimicrobials are the ideal mode of onychomycosis treatment for efficient drug delivery and avoidance of sytemic effects associated with oral medications. However, high treatment costs, tissue penetration limitations, and low cure rates have continued to pose major challenges. To capitalize on the progress made by topical efinaconazole solution, efinaconazole was combined with inexpensive, previously-characterized nitric oxide releasing nanoparticles (NO-np), which have been shown to offer sustained nitric oxide release over time and enhanced barrier penetration, while exerting broad spectrum antimicrobial and immunomodulating properties. NO-np were combined with efinaconazole in varying concentrations and applied against reference strains of Trichophyton rubrum using a checkerboard method. Results demonstrated synergism of NO-np+efinaconazole against T. rubrum, which is noteworthy given the barriers present in the topical treatment of onychomycosis, and the multiple potential benefits offered by NO-np. Overall, this study illustrates the untapped potential of nanotechnology in the treatment of disorders of the skin, hair, and nails where drug delivery remains a challenge. J Drugs Dermatol. 2018;17(7):717-720.

UR - http://www.scopus.com/inward/record.url?scp=85055616350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055616350&partnerID=8YFLogxK

M3 - Article

C2 - 30005092

AN - SCOPUS:85055616350

VL - 17

SP - 717

EP - 720

JO - Journal of Drugs in Dermatology

JF - Journal of Drugs in Dermatology

SN - 1545-9616

IS - 7

ER -